MeSH tree: D12.776.780.551
In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring levels of a protein associated with placental function and development.
Oct 21, 2025
0
6
Two simple blood tests could help to predict which pregnant women with high blood pressure are at risk of serious complications, including seizures, stillbirth and newborn death, a new study conducted in Sierra Leone has ...
Sep 19, 2025
0
21
A research team from Sinai Health and the University of Toronto has identified a way to determine which mothers are more likely to deliver a baby preterm, raising the possibility of developing a universal screening strategy.
Feb 19, 2025
0
21
To identify and follow blood vessel-related changes in the brain that contribute to cognitive impairment and dementia, researchers and clinicians typically rely on MRI to evaluate "downstream" biological markers—those at ...
Dec 18, 2024
0
20
PARP inhibitors have improved survival of breast cancer patients with BRCA1/2 mutations, but the drugs eventually stop working and the cancer returns.
Aug 15, 2024
0
45
A single test to speed up diagnosis of a serious disease in pregnant women does not need to be repeated, new research has found.
Feb 8, 2024
0
38
A new study led by Professor Laura Magee, has found that among pregnancies with clinical risk factors for pre-eclampsia or fetal growth restriction, measuring serum placental growth factor (PlGF) at the time of the routine ...
Nov 14, 2023
0
38
For decades, doctors have typically relied on measuring blood pressure and proteins in urine to determine whether a woman will develop preeclampsia, a serious hypertensive disorder that affects roughly 2% to 8% of pregnant ...
Jun 12, 2023
0
37
Measuring a key blood molecule may help doctors diagnose whether or how much impaired blood flow to a patient's brain is contributing to dementia or cognitive problems, according to a new study led by a UCLA Health researcher.
Feb 23, 2023
0
54
Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led ...
Jul 14, 2022
0
56
